BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Mankind Pharma Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543904
ISIN Demat
INE634S01028
Book Value (Rs)
375.7344945
NSE Symbol
MANKIND
Divident Yield %
0
Market Cap
(Rs In Cr.)
88,962
P/E (TTM)
50.35
EPS (TTM)
42.8
Face Value
(Rs)
1
Back
Mankind Pharma consolidated net profit rises 7.50% in the December 2025 quarter
13-Feb-26   Hrs IST

Net profit of Mankind Pharma rose 7.50% to Rs 408.75 crore in the quarter ended December 2025 as against Rs 380.23 crore during the previous quarter ended December 2024. Sales rose 11.52% to Rs 3567.20 crore in the quarter ended December 2025 as against Rs 3198.79 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales3567.203198.79 12
OPM %25.7725.51 -
PBDT838.19675.50 24
PBT615.59488.33 26
NP408.75380.23 8

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)